tiprankstipranks
Blurbs

Analysts Offer Insights on Healthcare Companies: Novavax (NVAX), Axsome Therapeutics (AXSM) and Roche Holding AG (OtherRHHVF)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Novavax (NVAXResearch Report), Axsome Therapeutics (AXSMResearch Report) and Roche Holding AG (RHHVFResearch Report).

Novavax (NVAX)

In a report released yesterday, Roger Song from Jefferies maintained a Buy rating on Novavax, with a price target of $190.00. The company’s shares closed last Tuesday at $51.06, close to its 52-week low of $34.88.

According to TipRanks.com, Song is ranked 0 out of 5 stars with an average return of -27.9% and a 19.5% success rate. Song covers the Healthcare sector, focusing on stocks such as Nektar Therapeutics, Replimune Group, and GlycoMimetics.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Novavax with a $138.00 average price target, a 162.6% upside from current levels. In a report issued on June 24, Cantor Fitzgerald also maintained a Buy rating on the stock with a $168.00 price target.

See the top stocks recommended by analysts >>

Axsome Therapeutics (AXSM)

Jefferies analyst Chris Howerton maintained a Buy rating on Axsome Therapeutics yesterday and set a price target of $77.00. The company’s shares closed last Tuesday at $37.96.

According to TipRanks.com, Howerton is ranked 0 out of 5 stars with an average return of -17.8% and a 28.7% success rate. Howerton covers the Healthcare sector, focusing on stocks such as Harmony Biosciences Holdings, Applied Molecular Transport, and Finch Therapeutics Group.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Axsome Therapeutics with a $56.67 average price target, representing a 58.1% upside. In a report issued on June 27, Mizuho Securities also maintained a Buy rating on the stock with a $49.00 price target.

Roche Holding AG (RHHVF)

In a report released today, Richard Vosser from J.P. Morgan maintained a Hold rating on Roche Holding AG, with a price target of CHF370.00. The company’s shares closed last Tuesday at $323.69.

Vosser has an average return of 13.8% when recommending Roche Holding AG.

According to TipRanks.com, Vosser is ranked #541 out of 7908 analysts.

Roche Holding AG has an analyst consensus of Moderate Buy, with a price target consensus of $404.94.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on NVAX:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos
---

Latest News Feed